Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Nexvet Biopharma plc | nvet-ex231_973.htm |
| EX-10.7 - EX-10.7 - Nexvet Biopharma plc | nvet-ex107_816.htm |
| EX-10.10 - EX-10.10 - Nexvet Biopharma plc | nvet-ex1010_784.htm |
| EX-31.2 - EX-31.2 - Nexvet Biopharma plc | nvet-ex312_201506307.htm |
| EX-31.1 - EX-31.1 - Nexvet Biopharma plc | nvet-ex311_201506306.htm |
| EX-32.1 - EX-32.1 - Nexvet Biopharma plc | nvet-ex321_201506308.htm |
| 10-K - 10-K - Nexvet Biopharma plc | nvet-10k_20150630.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report on Form 10-K of Nexvet Biopharma public limited company (the “Company”) for the period ended June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: September 3, 2015 |
|
By: |
/s/ Damian Lismore |
|
|
|
|
Damian Lismore |
|
|
|
|
Chief Financial Officer |
|
|
|
|
(Principal Financial and Accounting Officer) |